COGT

Cogent Biosciences Inc

• Simply Wall St·5d ago

  3 Reasons Cogent Biosciences (COGT) Looks Pricey After Its FDA Filing

• PUBT·06/30 12:02

  Cogent Biosciences submits FDA NDA for bezuclastinib in advanced systemic mastocytosis

• Simply Wall St·06/30 03:20

  Why Cogent Biosciences (COGT) Is Up 6.7% After Russell Index Removal Reshapes Its Investor Base

• Seeking Alpha·06/24 13:45

  10 mid-cap U.S. healthcare stocks with the strongest momentum grades

• Simply Wall St·06/20 12:21

  New Bezuclastinib and JAK2 Data Could Be A Game Changer For Cogent Biosciences (COGT)

• Simply Wall St·06/18 15:32

  Cogent Biosciences (COGT) Stock Can APEX Trial Progress Justify A 10.6x P B Ratio

• TipRanks·06/17 13:35

  H.C. Wainwright Sticks to Its Buy Rating for Cogent Biosciences (COGT)

• TipRanks·06/15 14:19

  Wedbush Keeps Their Buy Rating on Cogent Biosciences (COGT)

• Seeking Alpha·06/14 13:13

  Cogent Biosciences: A Pre-Commercial Biotech With Commercial-Stage Leverage

• Simply Wall St·06/12 22:26

  Cogent Biosciences (COGT) Is Up 6.7% After Positive PEAK Trial Data and FDA Priority Review - What's Changed

• Reuters·06/12 12:13

  COGENT BIOSCIENCES - TO SUBMIT APEX NDA IN JUNE 2026

• PUBT·06/12 12:02

  Cogent Biosciences says mutant-selective JAK2 V617F inhibitor CGT1145 on track for IND in 2026

• PUBT·06/12 12:01

  Cogent says bezuclastinib posts 65% response rate in APEX trial for advanced systemic mastocytosis

• TipRanks·06/11 21:55

  Cogent Biosciences Shareholders Back Board, Governance Proposals